CSL Limited

CSL Limited engages in the research, development, manufacture, marketing, and distribution of biopharmaceutical and allied products. It offers plasma-derived and recombinant products for the treatment of hemophilia and other coagulation disorders; immunoglobulins for the prevention and treatment of immune disorders; plasma volume expanders to treat acute blood loss and severe burns; that inhibit the formation of blood clots; and wound-healing agents used during surgical procedures. The company also provides influenza vaccine; various prescription drugs used in dermatology, urology, analgesia, and neurology; vaccines for the immunization of Children against tetanus, diphtheria, polio, and whooping cough; antivenoms; skincare and sun care products, and rescue medication for the treatment of severe allergic reaction; and in vitro diagnostic products for immunohaematology and snake venom detection. In addition, it offers toll fractionation services. The company, formerly known as Commonwealth Serum Laboratories Limited, was founded in 1916. It changed its name to CSL Limited in 1991. The company is headquartered in Melbourne, Australia.